Dezhan Healthcare Company Limited (000813.SZ) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. 000813.SZ files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.00% | 30.00% | Pass |
| Interest-bearing investments | 24.59% | 30.00% | Pass |
| Non-permissible income | 4.34% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 3.04% | 33.00% | Pass |
| Interest-bearing investments | 37.27% | 33.00% | Fail |
| Non-liquid assets | 57.92% | at least 20.00% | Pass |
| Non-permissible income | 4.34% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 3.04% | 33.33% | Pass |
| Cash + interest-bearing securities | 37.27% | 33.33% | Fail |
| Accounts receivable | 42.08% | 33.33% | Fail |
| Non-permissible income | 4.34% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 3.04% | 33.33% | Pass |
| Cash + interest-bearing securities | 37.27% | 33.33% | Fail |
| Accounts receivable | 42.08% | 50.00% | Pass |
| Non-permissible income | 4.34% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.89% | 33.00% | Pass |
| Cash + interest-bearing securities | 23.21% | 33.00% | Pass |
| Accounts receivable | 3.00% | 33.00% | Pass |
| Non-permissible income | 4.34% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.97% | 33.00% | Pass |
| Cash + interest-bearing securities | 24.21% | 49.00% | Pass |
| Accounts receivable | 3.12% | 49.00% | Pass |
| Non-permissible income | 4.34% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.97% | 33.33% | Pass |
| Cash + interest-bearing securities | 24.21% | 33.33% | Pass |
| Accounts receivable | 27.33% | 49.00% | Pass |
| Non-permissible income | 4.34% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 48.80 | NEUTRAL |
| Stochastic %K (14) | 38.10 | NEUTRAL |
| CCI (20) | -32.11 | NEUTRAL |
| Williams %R (14) | -61.90 | NEUTRAL |
| MACD (12,26,9) | -0.00 | SELL |
| ROC (10) | -2.59 | SELL |
| Momentum (10) | -0.09 | SELL |
| EMA (10) | 3.45 | SELL |
| SMA (10) | 3.45 | SELL |
| EMA (20) | 3.43 | SELL |
| SMA (20) | 3.41 | SELL |
| EMA (30) | 3.41 | SELL |
| SMA (30) | 3.43 | SELL |
| EMA (50) | 3.39 | SELL |
| SMA (50) | 3.37 | BUY |
| EMA (100) | 3.43 | SELL |
| SMA (100) | 3.38 | BUY |
| EMA (200) | 3.66 | SELL |
| SMA (200) | 3.60 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Drug Manufacturers - Specialty & Generic
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, hydroxyurea tablets, colchicine tablet, and oseltamivir phosphate capsules. It also involved in the provision of biopeptides, industrial hemp, and medical service business. Dezhan Healthcare Company Limited was founded in 1980 and is based in Beijing, the People's Republic of China.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-08 · Asset managers net 912361 (-21819)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.